Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers
Clinical trial NCT05043987 · WITHDRAWN
Trial details
- NCT number
- NCT05043987
- Sponsor
- Conjupro Biotherapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-16
- Primary completion
- 2022-11-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.